✦ LIBER ✦

RANTES (CCL5) production during primary respiratory syncytial virus infection exacerbates airway disease

✍ Scribed by Kim K. Tekkanat; Hussein Maassab; Allison Miller; Aaron A. Berlin; Steven L. Kunkel; Nicholas W. Lukacs

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 202 KB
Volume: 32
Category: Article
ISSN: 0014-2980
DOI: 10.1002/1521-4141(200211)32:11<3276::aid-immu3276>3.0.co;2-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Respiratory syncytial virus-induced CCL5

Respiratory syncytial virus-induced CCL5/RANTES contributes to exacerbation of allergic airway inflammation

✍ Alison E. John; Aaron A. Berlin; Nicholas W. Lukacs 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

Inhibition of respiratory syncytial viru

Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5)

✍ Matthew B. Elliott; Paul W. Tebbey; Karin S. Pryharski; Catherine A. Scheuer; To 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 1 views

## Abstract Respiratory syncytial virus (RSV) is a major cause of respiratory tract disease in infants, aged adults, and immunosuppressed patients. The only approved medicines for RSV disease are administration of prophylatic antibodies or treatment with a synthetic nucleoside. Both approaches are